Clinical Trial Update: Study of Nimotuzumab to Treat Esophageal Squamous Cell Carcinoma. [Phase 1, Phase 2]

View source ↗

Summary

This document reports an ongoing Phase 1/2 clinical trial evaluating nimotuzumab for esophageal squamous cell carcinoma; the status is listed as UNKNOWN with no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Peking University | Conditions: Esophageal Squamous Cell Cancer | Phase 1, Phase 2 | Status: UNKNOWN